Invesaro

Stocks LUCY Financial statements

Financial statements

Innovative Eyewear Inc financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Innovative Eyewear Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2022FY2022FY2023FY2024FY2025
Revenue0.690.661.151.642.66
Cost of revenue0.540.721.271.422.09
Gross profit0.15-0.06-0.120.220.57
Research and development0.090.520.660.820.73
Selling and marketing1.772.062.052.712.97
General and administrative1.392.83.894.475.23
Operating expenses3.355.526.748.149.06
Interest expense0.040.110
Other non-operating income-0.110.190.160.9
Net income-3.24-5.68-6.66-7.77-7.59
EPS, basic-15.01-10.87-5.19-1.90
EPS, diluted-15.01-10.87-5.19-1.90
Shares, basic (weighted)0.611.53.99
Shares, diluted (weighted)0.380.611.53.99

Balance sheet

FY2022FY2022FY2023FY2024FY2025
Cash and equivalents0.083.594.292.636.51
Receivables0.040.110.090.110.14
Inventory0.280.090.530.831.75
Other current assets00.040.060.060
Total current assets0.644.245.629.249.44
Property, plant and equipment0.020.120.150.110.06
Intangible assets0.090.140.290.450.56
Other non-current assets0.080.070.040.08
Total assets0.824.696.229.8410.1
Accounts payable0.170.280.580.690.99
Deferred revenue0.030.0400.06
Total current liabilities0.620.60.620.741.05
Total liabilities0.620.670.660.741.07
Paid-in capital4.8414.322.533.841.4
Retained earnings-4.62-10.3-17-24.7-32.3
Shareholders' equity0.214.025.569.19.07
Total equity0.214.025.569.19.07
Total liabilities and equity0.824.696.229.8410.1
Shares outstanding6.060.420.752.455.48

Cash flow statement

FY2022FY2022FY2023FY2024FY2025
Net income-3.24-5.68-6.66-7.77-7.59
Depreciation and amortization00.020.060.110.07
Stock-based compensation1.331.470.940.770.74
Change in receivables-0.04-0.18-0-0-0.04
Change in inventory-0.250.05-0.56-0.3-0.91
Change in payables0.160.070.30.090.19
Cash from operations-1.21-3.22-5.77-6.74-7.28
Capital expenditures-0.02-0.12-0.08-0.06-0.07
Purchases of investments-1.27
Cash from investing-0.12-0.22-0.2-5.164.48
Stock issued0.490.02
Cash from financing1.396.966.6610.26.68
Net change in cash0.053.510.7-1.663.88
Free cash flow-1.23-3.35-5.84-6.8-7.35

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.95 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin22.8%Gross profit / revenue.
Net margin-225.3%Net income / revenue.
Operating cash flow margin-211.1%Cash from operations / revenue.
Return on equity (ROE)-111.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-102.9%Net income / average total assets.
R&D / revenue15.4%Research and development expense / revenue.
Stock-based pay / revenue23.3%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue1.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y62.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y59.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y163.7%Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-0.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y31.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y3.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y29.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y166.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y119.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio12.1xCurrent assets / current liabilities.
Quick ratio4.61x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio4.36x(Cash + short-term investments) / current liabilities.
Liabilities / assets7.7%Total liabilities / total assets.
Working capital$6.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets8.4%(Goodwill + intangible assets) / total assets.
Tangible book value$6.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.46xRevenue / average total assets.
Fixed asset turnover109xRevenue / average property, plant and equipment.
Inventory turnover1.49xCost of revenue / average inventory.
Days inventory246 days365 x average inventory / cost of revenue.
Receivables turnover25.0xRevenue / average receivables.
Days sales outstanding15 days365 x average receivables / revenue.
Days payables69 days365 x average accounts payable / cost of revenue.
Cash conversion cycle191 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.20Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.53Revenue / diluted weighted shares.
Operating cash flow per share-$1.12Cash from operations / diluted weighted shares.
Book value per share$1.08Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.98Tangible book value / shares outstanding.
Cash per share$0.38(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$8.2MShare price x shares outstanding.
Enterprise value$5.7MMarket cap + total debt - cash - short-term investments.
P/S2.40xMarket cap / revenue.
P/B1.19xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.30xMarket cap / tangible book value, when positive.
EV/Sales1.68xEnterprise value / revenue.
Earnings yield-94.0%Net income / market cap (the inverse of P/E).
What was Innovative Eyewear Inc's revenue in fiscal 2025?

Innovative Eyewear Inc reported revenue of $2.7M for fiscal 2025, 62.6% higher than the year before.

Was Innovative Eyewear Inc profitable in fiscal 2025?

No. It reported a net loss of $7.6M.

How much free cash flow did Innovative Eyewear Inc generate in fiscal 2025?

Cash from operations of $7.3M minus capital expenditures of $72.5K left free cash flow of -$7.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Innovative Eyewear Inc